More than 20,000 women have been diagnosed with cancer since they joined the WHI. The LILAC study aims to learn more about cancer treatments and their effects on the lives and health of women. The LILAC study will include women diagnosed with breast cancer, colorectal cancer, lung cancer, endometrial cancer, ovarian cancer, melanoma, leukemia, and lymphoma. In July, the Clinical Coordinating Center will begin mailing to about 10,000 current WHI participants who have had a diagnosis of cancer. This mailing will include a letter about the study, a consent form, a tissue and medical records release form, and a LILAC questionnaire with questions about you during and after cancer treatment.
If you join the LILAC study, we will ask you to fill out the questionnaire and give us permission to review your medical records and tumor tissue related to the cancer. This valuable information will help us learn more about cancer treatment and may help improve the lives of women in the future.
If you have any questions about the LILAC study, please call the toll free message line 1-855-332-1930.